Discover
UTHR
United Therapeutics Corporation
547.15
1 x 549.35
1 x 541.72
bid
ask
+
5.32
0.98%
1 @ 04:00 PM
547.15 +0.00 (0.00%)
| Ytd | 12.29% | |
| 1y | 85.34% |
536.93
day range
549.66
272.12
52 week range
609.35
| Open | 542.65 | Prev Close | 541.83 | Low | 536.93 | High | 549.66 | Mkt Cap | 23.22B |
| Vol | 407.61K | Avg Vol | 505.80K | EPS | 27.04 | P/E | 20.23 | Forward P/E | 17.05 |
| Beta | 0.57 | Short Ratio | 4.46 | Inst. Own | 102.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 560.00 | 200-d Avg | 503.35 | 1yr Est | 665.23 |
| Income Statement | |||
| Total Revenue | 781.50M | ||
| Revenues (USD) | 781.50M | ||
| Cost of Revenue | 133.40M | ||
| Gross Profit | 648.10M | ||
| Operating Expenses | 322.30M | ||
| Research and Development Expense | 138.20M | ||
| Selling, General and Administrative Expense | 184.10M | ||
| Operating Income | 325.80M | ||
| Interest Expense | 3.00M | ||
| Income Tax Expense | 43.40M | ||
| Net Income | 274.90M | ||
| Net Income Common Stock | 274.90M | ||
| Net Income Common Stock (USD) | 274.90M | ||
| Consolidated Income | 274.90M | ||
| Earnings per Basic Share | 6.32 | ||
| Earnings per Basic Share (USD) | 6.32 | ||
| Earnings per Diluted Share | 5.82 | ||
| Earning Before Interest & Taxes (EBIT) | 321.30M | ||
| Earning Before Interest & Taxes (USD) | 321.30M | ||
| Weighted Average Shares | 43.50M | ||
| Weighted Average Shares Diluted | 47.20M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.28B | ||
| Cash and Equivalents (USD) | 1.28B | ||
| Investments | 2.19B | ||
| Investments Current | 874.00M | ||
| Investments Non-Current | 1.32B | ||
| Trade and Non-Trade Receivables | 312.00M | ||
| Current Assets | 2.87B | ||
| Property, Plant & Equipment Net | 1.84B | ||
| Total Assets | 6.71B | ||
| Current Liabilities | 599.10M | ||
| Total Liabilities | 813.10M | ||
| Accumulated Retained Earnings (Deficit) | 8.83B | ||
| Accumulated Other Comprehensive Income | -10.20M | ||
| Shareholders Equity | 5.90B | ||
| Shareholders Equity (USD) | 5.90B | ||
| Assets Non-Current | 3.84B | ||
| Goodwill and Intangible Assets | 115.50M | ||
| Inventory | 178.30M | ||
| Liabilities Non-Current | 214.00M | ||
| Trade and Non-Trade Payables | 498.30M | ||
| Tax Assets | 335.40M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 22.60M | ||
| Net Cash Flow from Financing | -1.48B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -277.40M | ||
| Capital Expenditure | -100.80M | ||
| Issuance (Purchase) of Equity Shares | -1.43B | ||
| Net Cash Flow from Investing | 743.70M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 844.50M | ||
| Net Cash Flow from Operations | 463.30M | ||
| Share Based Compensation | 33.90M | ||